Triple inhaled therapy with twice-daily budesonide, at two doses, glycopyrrolate and formoterol reduced the rate of moderate or severe COPD exacerbations compared with two dual-combination therapies, according to data from the ETHOS trial. “For the first time, triple therapy with half the dose of inhaled corticosteroid was shown to have greater efficacy than higher-dose inhaled
More than 1,600 health care professionals celebrated the approval of Rezdiffra, the first treatment for adults with metabolic dysfunction-associated steatohepatitis, according to a global online…
BOSTON — Most people in the United States do not get enough vitamin D, but supplementation helps patients reach the daily recommended dietary allowance, according…
In this Healio Video Perspective from the ASCRS meeting, John D. Sheppard, MD, MMSc, FACS, discusses a post hoc analysis of two clinical trials investigating…
Among patients with chronic coronary syndrome, women were less likely than men to be treated with lipid-lowering therapy, researchers reported at ESC Preventive Cardiology 2024.Women…
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data…
Few areas in cardiology are as active as development and implementation of medical therapies for heart failure, and few people are as familiar with that…
HOUSTON — Peter J. Hotez, MD, PhD, has been working in vaccine development for more than 40 years.
A biosimilar for golimumab has demonstrated therapeutic equivalence in rheumatoid arthritis, with no clinically meaningful safety differences, according to a press release from the manufacturer.…
In the last few years, major strides have been made in the fight to control malaria, including the first two malaria vaccines ever recommended for…
The FDA announced this week that testing has identified genetic traces of highly pathogenic avian influenza virus in pasteurized cow milk samples collected in the…
